Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00139204 | Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients | completed | N/A | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00541281 | Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer | completed | Phase 2 | 150 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | Oct 27, 2009 |
| clinicaltrials |
| NCT00997464 | An Exploration of Genetic Testing for Prostate Cancer Susceptibility | unknown | — | 200 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 19, 2009 | clinicaltrials |
| NCT00003391 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Oct 12, 2009 | clinicaltrials |
| NCT00494338 | Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer | terminated | Phase 2 | 6 | SanofiINDUSTRY | 1 | Oct 1, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00928603 | Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment | unknown | Phase 1 | 100 | Università Vita-Salute San RaffaeleOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00573820 | Far Infrared Radiation Treatment for Prostate Cancer | unknown | Phase 1 | 4 | GAAD Medical Research Institute Inc.OTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00152789 | Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy | completed | Phase 2 | 40 | University Health Network, TorontoOTHER | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00133900 | Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy(IMMC-38) | unknown | — | 276 | ImmuniconINDUSTRY | 1 | Jul 28, 2009 | clinicaltrials |
| NCT00230386 | Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma | completed | Phase 1 / Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00581516 | Molecular Urine Tests for Prostate Cancer | completed | — | 100 | University of California, IrvineOTHER | 1 | Jun 5, 2009 | clinicaltrials |
| NCT00895466 | Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients | unknown | Phase 1 / Phase 2 | 12 | Pepscan TherapeuticsINDUSTRY | 1 | May 8, 2009 | clinicaltrials |
| NCT00513721 | Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy | completed | — | 400 | Corewell Health EastOTHER | 1 | May 5, 2009 | clinicaltrials |
| NCT00241475 | Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy | completed | Phase 2 | 30 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00635856 | Open Label Trial to Assess Iressa in Prostate Cancer Patients | completed | Phase 2 | 100 | AstraZenecaINDUSTRY | 0 | Apr 23, 2009 | clinicaltrials |
| NCT00120939 | Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | completed | Phase 1 | 25 | Pharmacyclics LLC.INDUSTRY | 1 | Apr 3, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00695851 | Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. | completed | Phase 1 | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 30, 2009 | clinicaltrials |
| NCT00291005 | PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone | completed | Phase 2 | 42 | SanofiINDUSTRY | 1 | Mar 27, 2009 | clinicaltrials |
| NCT00870714 | Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study(IST 16167) | unknown | N/A | 20 | Kansas City Veteran Affairs Medical CenterFED | 1 | Mar 27, 2009 | clinicaltrials |
| NCT00868868 | Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy | unknown | — | 400 | Groupe de recherche en Urologie de la MauricieOTHER | 1 | Mar 25, 2009 | clinicaltrials |
| NCT00043576 | ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere | unknown | Phase 2 / Phase 3 | 250 | NovaceaINDUSTRY | 2 | Mar 12, 2009 | clinicaltrials |
| NCT00200824 | Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00619996 | Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer(P1) | completed | Phase 2 | 43 | Italian Trial in Medical OncologyOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00122005 | GVAX in Advanced Prostate Cancer Patients Made Lymphopenic | unknown | Phase 1 / Phase 2 | 18 | Providence Health & ServicesOTHER | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00703768 | Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year | unknown | — | 300 | Urology South Shore Research Inc.OTHER | 1 | Feb 17, 2009 | clinicaltrials |
| NCT00841113 | Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer | completed | Phase 3 | 177 | Speciality European Pharma LimitedINDUSTRY | 0 | Feb 11, 2009 | clinicaltrials |
| NCT00111618 | Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer | completed | Phase 2 | 70 | Antisoma ResearchINDUSTRY | 1 | Jan 30, 2009 | clinicaltrials |
| NCT00007540 | Study of Prostate Cancer in Black and White U.S. Veterans | completed | — | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00018538 | Calcifidol Therapy in Men With Cancer | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00108264 | Tumor RNA Transfected Dendritic Cell Vaccines | completed | Phase 1 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00657982 | Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer | unknown | Phase 2 | 15 | Sheba Medical CenterOTHER_GOV | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00167648 | Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer(NE2) | completed | Phase 2 | 17 | University of WashingtonOTHER | 1 | Jan 19, 2009 | clinicaltrials |
| NCT00174863 | Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer(ODYSSEY) | completed | Phase 2 | 232 | SanofiINDUSTRY | 13 | Dec 23, 2008 | clinicaltrials |
| NCT00559429 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer(Tax-Sam) | completed | Phase 1 | 13 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 17, 2008 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00511498 | Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical Prostatectomy | completed | N/A | 100 | Johns Hopkins UniversityOTHER | 1 | Dec 1, 2008 | clinicaltrials |
| NCT00394810 | Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 2 | 21 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00090376 | Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy | completed | Phase 2 | 240 | Eisai Inc.INDUSTRY | 1 | Nov 7, 2008 | clinicaltrials |
| NCT00089856 | GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | terminated | Phase 3 | 626 | Cell GenesysINDUSTRY | 8 | Nov 5, 2008 | clinicaltrials |
| NCT00777452 | A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer | completed | — | 93 | Samsung Medical CenterOTHER | 1 | Oct 22, 2008 | clinicaltrials |
| NCT00007579 | To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population. | completed | — | — | US Department of Veterans AffairsFED | 1 | Oct 17, 2008 | clinicaltrials |
| NCT00764166 | A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel(RisingPSA) | unknown | Phase 3 | 254 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 1, 2008 | clinicaltrials |
| NCT00546039 | Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer | unknown | Phase 2 | 47 | University Hospital, AkerOTHER | 1 | Sep 30, 2008 | clinicaltrials |
| NCT00133224 | Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients | terminated | Phase 3 | 408 | Cell GenesysINDUSTRY | 10 | Sep 23, 2008 | clinicaltrials |
| NCT00056654 | Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer | completed | N/A | 164 | AbbottINDUSTRY | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00104130 | Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer | terminated | Phase 2 | 53 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00425204 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | completed | Phase 2 | 31 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00061035 | Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma | completed | Phase 1 | 18 | Cosmo BioscienceINDUSTRY | 1 | Aug 28, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Nov 2, 2009source: clinicaltrials